PCM
EXAS

Poehling Capital Management’s Exact Sciences EXAS Stock Holding History

Poehling Capital Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-228
Closed -$14K – 161
2018
Q2 		$14K Hold
228
– – 0.01% 213
2018
Q1 		$9K Hold
228
– – 0.01% 239
2017
Q4 		$12K Buy
+228
New +$12.2K 0.01% 210

Other funds holding EXAS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 17.47% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Poehling Capital Management's EXAS Position: Q3 2018 in Review

Poehling Capital Management sold out of Exact Sciences (EXAS) in Q3 2018, closing a stake of 228 shares — an estimated $14K sold.

Poehling Capital Management first reported a position in EXAS in Q4 2017 and held it in 3 quarters. The position peaked at $14K in Q2 2018. 365 funds tracked by Wall St. Rank hold EXAS as of Q3 2018.

  • Poehling Capital Management reported no remaining Exact Sciences position as of Q3 2018 after selling out during the quarter.
  • Poehling Capital Management sold 228 Exact Sciences shares in Q3 2018, an estimated $14K.
  • Poehling Capital Management first reported a position in Exact Sciences in Q4 2017 and held it in 3 quarters.
  • Poehling Capital Management's Exact Sciences position peaked at $14K in Q2 2018.
  • 365 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2018.

Based on Poehling Capital Management's 13F filing for Q3 2018, filed 13 Nov 2018.